Health DG: Will take four months to evaluate Pfizer trial data


PUTRAJAYA: It will take up to four months for the National Pharmaceutical Regulatory Agency (NPRA) to evaluate the clinical trial data provided by pharmaceutical giant Pfizer on the Covid-19 vaccine it has developed.

Health director-general Tan Sri Dr Noor Hisham Abdullah said the NPRA received a formal application from Pfizer on Dec 15 to have its Covid-19 vaccine registered in Malaysia.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Nation

Cops to work with Myanmar and int'l agencies to verify claims of Jho Low's whereabouts
Sarawak to host 15th World Congress on Design and Health in 2026
Perikatan willing to resume MOU talks if terms are fair, says Hamzah
70yo man arrested for murder in Sabah
Rural and Regional Ministry introduces smart village concept to empower rural communities
Couple and associate charged with trafficking 51.9kg of meth in Perak
Trainees urged to uphold integrity and avoid corruption, says IGP
UPNM cadet claims trial to causing hurt to junior using spiked boot in latest bullying case
Mandatory recertification, tougher penalties needed for heavy vehicle safety, says Lam Thye
More than 60 flood victims evacuated in Perak, rising river levels in Terengganu, Kelantan

Others Also Read